Company Filing History:
Years Active: 1980-1987
Title: Innovations in Oncology: The Contributions of Augusto De Barbieri
Introduction
Augusto De Barbieri is a notable inventor based in Milan, Italy. He has made significant contributions to the field of oncology through his innovative pharmaceutical compositions. With a total of 4 patents to his name, De Barbieri's work focuses on the treatment of malignant tumor cells.
Latest Patents
De Barbieri's latest patents include groundbreaking advancements in the administration of tripeptide compounds. One of his notable inventions is a pharmaceutical composition designed for intravenous or intraperitoneal administration, aimed at treating malignant tumor cells in laboratory animals. This composition utilizes a pharmaceutically acceptable excipient combined with a tripeptide compound as the active ingredient. The tripeptide is formed from dichlorodiethylaminophenylalanine, parafluorophenylalanine, and methionine. Another significant patent describes compounds with high anti-tumor activity and moderate toxicity, which are also tripeptides formed from the same amino acids. These compounds are particularly useful in the treatment of malignant tumors.
Career Highlights
Augusto De Barbieri has established himself as a leading figure in pharmaceutical innovation. His work at Proter S.p.a. has allowed him to focus on developing effective treatments for cancer. His dedication to research and development has led to advancements that could potentially improve patient outcomes in oncology.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Augusto De Barbieri's contributions to the field of oncology through his innovative patents highlight the importance of research in developing effective cancer treatments. His work continues to inspire advancements in pharmaceutical science.